
United States · Information technology & services startup
ZeOmega is a healthcare software company based in Plano, Texas, founded in 2001.
Funding reportedLast round: Venture (Round not Specified)
Follow ZeOmega and see its new rounds in your feed.Start following
ZeOmega is a healthcare software company based in Plano, Texas, founded in 2001.
It specializes in population health management (PHM) solutions for health plans, risk-bearing organizations, and value-based care entities. The company operates in the B2B SaaS sector within HealthTech and Healthcare IT, serving over 40 million lives through its advanced platform. The flagship product, JivaTM Healthcare Enterprise Management Platform, streamlines workflows and enhances clinical intelligence. Key services include care management, utilization management, and solutions for improving quality scores. ZeOmega also addresses social determinants of health and offers a machine-learning-powered prior authorization solution called Smart Auth Optimizer. The company is recognized for its excellence, having received the Best in KLAS award for Payer Care Management Solutions in 2022, 2023, and 2024. With a commitment to delivering high-quality, cost-effective care, ZeOmega supports a diverse client base, including commercial health plans, Medicaid and Medicare Advantage plans, health systems, and physician groups.
Funding, as reported
From ZeOmega's own website: 4 on the team.
What they build
Known for
population health managementhealth carehealth plansintegrated health managementhealthcare analyticscustomizable care workflowscomputer & network securityhealthcare solutionsinteroperabilitycare qualityenterprisesinformation technology & servicesrisk stratification modelsrisk-bearing organizationscompliance metricshealthcare data security
Built with from their website
GitHub ActionsAzure DevopsDockerGoogle Tag ManagerDriftAmazon CloudFrontJUnitTableauAtlassianMicrosoft PowerPoint
Google AdsAbsorbFivetranCloudFlareViewport MetaZoomdataLocustSqlalchemy
Add your raise, your deck and your story, and put ZeOmega in front of investors. Or tell us what we have wrong.